Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Then BMS and Pfizer won a critical court ruling in August 2020 that extended their ability to block generic entry until 2026, and subsequent litigation outcomes shifted the final expected generic entry date to April 2028 [8]
Did you see his last fight
What We Saw in 2026
Novo Nordisk has structured their portfolio to keep the diabetes indication (Ozempic) and weight management indication (Wegovy) as separate products with separate licences, even though the drug is identical
US$ 22.35
US$ 23.99
US$ 23.80
US$ 25.46
US$ 29.11
US$ 27.31
